Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific
Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany – limitations of the ‘sickest first’-concept
✍ Scribed by Tobias J. Weismüller; Panagiotis Fikatas; Jan Schmidt; Ana P. Barreiros; Gerd Otto; Susanne Beckebaum; Andreas Paul; Markus N. Scherer; Hartmut H. Schmidt; Hans J. Schlitt; Peter Neuhaus; Jürgen Klempnauer; Johann Pratschke; Michael P. Manns; Christian P. Strassburg
- Book ID
- 110917495
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 298 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo
We examined the impact of the Model for End-Stage Liver Disease (MELD) organ allocation scheme on 44 patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver transplantation (OLT) between February 2002 and January 2003, and compared the outcome with 58 patients listed in the 4 years be
Renal function has a significant impact on early mortality in patients with cirrhosis. However, creatinine and creatinine-based equations are inaccurate markers of renal function in cirrhosis. The aim of this study was to reassess correlations between creatinine-based equations and measured glomerul